VJVirtual | Risk assessment tools for soft tissue sarcomas

Robin Jones • 1 May 2025

Sarcoma Imatinib

Robin Jones, MD, The Royal Marsden Hospital, London, UK, comments on the use of nomograms in soft tissue sarcomas, highlighting the importance of discussing the pros and cons of post-operative chemotherapy with patients and families, particularly given the limited evidence base for this treatment. Prof. Jones emphasizes that nomograms, such as the SARCULATOR or PERSARC, can be a valuable tool in refining risk assessments and predicting the risk of recurrence. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.